Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF
Recruiting
N/A
Interventional Study
Infertility
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 20 – 42
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 1,338 (estimated)
- Sponsor
- Northwest Women's and Children's Hospital, Xi'an, Shaanxi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare the clinical outcomes using different cetrorelix acetate in the context of a GnRH antagonist protocol for ovarian stimulation in women undergoing IVF or intracytoplasmic sperm injection(ICSI) treatment.The main question it aims to answer is whether the generic cetrorelix acetate is non-inferior to the reference product in the GnRH antagonist based prot…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Infertile couples plan to undergo IVF / ICSI pregnancy treatment into screening procedures and clinical study
1. All subjects should sign the informed consent form
2. Infertile women \<43 years old
3. With flexible GnRH antagonist
Exclusion Criteria:
* Subjects could …
Contacts